
Industry & Technology News
COVID-19’s mechanisms are becoming clearer, Abbott’s heart failure CMO says
Junkosha plans new medical plant by 2025 as expansion strategy accelerates
BioInteractions launches expanded medical product development partnership offering at MD&M West
Teamvantage launches new parent company Velosity
Edwards Lifesciences names Secant Group as its supplier of the year
New ‘ultrasound tornado’ device breaks down blood clots
Stratasys has its first FDA-cleared medical device
Honeywell introduces new bio-fiber for cardiovascular and orthopedic devices
Qosina appoints former EssilorLuxottica exec as its EVP
Trelleborg to expand biopharma manufacturing footprint in Europe
Sponsored Content See More >
Medical Device Business See More >

UCSD researchers develop wearable ultrasound device
Engineers and physicians at the University of California San Diego (UCSD) developed a wearable ultrasound device for assessing heart function and structure. The device, roughly the size of a postage stamp, features a wear time of up to 24 hours and works during strenuous exercise. According to the university, the researchers aim to make ultrasound…
3D Printing See More >

Stratasys has its first FDA-cleared medical device
Stratasys (NASDAQ: SSYS) today introduced its TrueDent resin for making 3D-printed dentures. TrueDent is the first FDA-cleared medical device for the company, which is based in Eden Prairie, Minnesota and Rehovot, Isreal. The Class II dental resin is made specifically for the fabrication of dental appliances, including removable dentures. The company had the resin developed…
Medical Device Applications See More >

COVID-19’s mechanisms are becoming clearer, Abbott’s heart failure CMO says
We still don’t fully understand why the SARS-CoV-2 virus is so transmissible and causes severe disease in some people but not others. But Dr. Philip Adamson, chief medical officer of Abbott’s heart failure business, said he’s amazed by how quickly we’re learning about COVID-19, building off our prior knowledge of coronaviruses and other viral pathogens.…
Medical Device Technologies See More >

Qosina appoints former EssilorLuxottica exec as its EVP
Qosina announced today that it’s appointed Lee Pochter as its executive vice president. Pochter has more than 20 years of expertise in product strategy, business development, sales, marketing and supply chain management. Most recently, he was VP of the Alternative Lens Group at EssilorLuxottica. “I look forward to the guidance Lee will bring to our…